Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03260283
Other study ID # StSavvasAH 2
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date August 16, 2017
Est. completion date December 31, 2019

Study information

Verified date March 2020
Source Saint Savvas Anticancer Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to assess the efficacy of subarachnoid anesthesia with low dose of pethidine (0.4mgkg-1) compared to administration of ropivacaine and fentanyl which is nowadays the common practice.


Recruitment information / eligibility

Status Completed
Enrollment 104
Est. completion date December 31, 2019
Est. primary completion date November 29, 2018
Accepts healthy volunteers No
Gender All
Age group 55 Years and older
Eligibility Inclusion Criteria:

- All patients about to be subjected to Transurethral resection of the prostate (TURP) and Transurethral resection of urinary bladder tumors (TUR)

- Signed informed consent

Exclusion Criteria:

- When subarachnoid block is contraindicated

- Patient's denial in performing subarachnoid anesthesia

- Failure of subarachnoid block (L1 dermatome in 30 minutes after intrathecal drug administration)

- Mental illness or drug abuse

- Estimated time of operation >90 minutes

Study Design


Related Conditions & MeSH terms

  • Low Dose of Pethidine for Subarachnoid Anesthesia

Intervention

Drug:
Pethidine hydrochloride
In Group I patients will be administered with low dose of pethidine hydrochloride (0.4 mgkg-1) diluted into normal saline up to 2 ml of total volume in order to perform subarachnoid anesthesia for urologic operations
Ropivacaine HCl Inj 7.5 MG/ML
In Group II patients will be administered with 2 ml of ropivacaine (0.75%)
Fentanyl
15 mcg of fentanyl will be added to the solution in order to perform subarachnoid anesthesia for urologic operations

Locations

Country Name City State
Greece Anticancer Hospital of Athens "Saint Savvas" Athens

Sponsors (1)

Lead Sponsor Collaborator
Saint Savvas Anticancer Hospital

Country where clinical trial is conducted

Greece, 

References & Publications (3)

Lewis RP, Spiers SP, McLaren IM, Hunt PC, Smith HS. Pethidine as a spinal anaesthetic agent--a comparison with plain bupivacaine in patients undergoing transurethral resection of the prostate. Eur J Anaesthesiol. 1992 Mar;9(2):105-9. — View Citation

Luck JF, Fettes PD, Wildsmith JA. Spinal anaesthesia for elective surgery: a comparison of hyperbaric solutions of racemic bupivacaine, levobupivacaine, and ropivacaine. Br J Anaesth. 2008 Nov;101(5):705-10. doi: 10.1093/bja/aen250. Epub 2008 Sep 2. — View Citation

Mohta M. Ropivacaine: Is it a good choice for spinal anesthesia? J Anaesthesiol Clin Pharmacol. 2015 Oct-Dec;31(4):457-8. doi: 10.4103/0970-9185.169050. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of subarachnoid anesthesia after administration of low dose of pethidine hydrochloride as the sole anesthetic agent, assessed by the pinprick test. Low dose of pethidine hydrochloride will be administered for subarachnoid anesthesia in patients subjected to urologic operations.The level of sensory block after subarachnoid anesthesia will be assessed by the pinprick test. 30 minutes after the intrathecal administration of the drug
Primary Efficacy of subarachnoid anesthesia after administration of low dose of pethidine hydrochloride as the sole anesthetic agent, assessed by the modified Bromage scale. The level of motor block will be assessed by the modified Bromage scale. 30 minutes after the intrathecal administration of the drug
Primary Efficacy of subarachnoid anesthesia after administration of low dose of pethidine hydrochloride as the sole anesthetic agent, assessed by the time of motor block establisment. Time of motor block establishment (Grade 2 in modified Bromage scale) will be recorded as well as the time of withdrawal. Failure of spinal block is considered when there is no block at the level of first lumbar vertebra 30 minutes after the intrathecal administration of the drugs and in these cases the patients are excluded from the study. 30 minutes after the intrathecal administration of the drug
Secondary Efficacy and length of time of analgesia provided by the low dose of pethidine hydrochloride. In order to assess the efficacy of analgesia provided by the low dose of pethidine hydrochloride we record the time at which patients ask analgesic for the first time after the operation. In the first 24 hours postoperatively
Secondary Percentage of postsurgical catheter-related bladder discomfort Assessment of discomfort will be made by a scale of four (1=no discomfort, 2=mild discomfort reported on questioning only, 3=moderate discomfort, urge to pass urine reported by the patient without questioning, 4= severe discomfort, urge to pass urine accompanied by behavioral responses, such as flailing limbs, strong vocal responses or attempts to pull the catheter out) Change from preoperative status to postoperative one at 0, 1, 2, 6, 24 hours postoperatively
Secondary Assessment of haemodynamic status of patients intraoperatively In order to assess the haemodynamic status of patients intraoperatively we record all episodes of hypotension (drop of systolic pressure >30% of value before the subarachnoid block. During the operation
Secondary Length of stay in postanesthesia care unit We record the total amount of time that patients stay in the postanesthesia care unit immediately after the operation until they are discharged to the ward. In order for a patient to be discharged to the ward he must have a score of more than >9 in Aldrete's Scoring system. Time of entry into postanesthesia care unit up to discharge to the ward or two hours time whichever comes first.
Secondary Adverse events We record all adverse events observed intraoperatively and 24 hours postoperatively All adverse events observed intraoperatively and in the first 24 hours postoperatively
Secondary Efficacy and length of time of analgesia provided by the low dose of pethidine hydrochloride. We also record the total amount of analgesics administered in morphine analogues in the first 24 hours postoperatively. In the first 24 hours postoperatively
Secondary Assessment of haemodynamic status of patients intraoperatively We also record the total amount of intravenous fluids administered intraoperatively. During the operation